Arnold C Hanish - Net Worth and Insider Trading
Arnold C Hanish Net Worth
The estimated net worth of Arnold C Hanish is at least $21 Million dollars as of 2024-11-13. Arnold C Hanish is the Chief Accounting Officer of Eli Lilly and Co and owns about 26,155 shares of Eli Lilly and Co (LLY) stock worth over $21 Million. Arnold C Hanish is the Director of Omeros Corp and owns about 12,400 shares of Omeros Corp (OMER) stock worth over $52,948. Arnold C Hanish is also the Director of Salarius Pharmaceuticals Inc and owns about 232 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $346. Details can be seen in Arnold C Hanish's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arnold C Hanish has not made any transactions after 2023-05-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Arnold C Hanish
Arnold C Hanish Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arnold C Hanish owns 3 companies in total, including Salarius Pharmaceuticals Inc (SLRX) , Omeros Corp (OMER) , and Eli Lilly and Co (LLY) .
Click here to see the complete history of Arnold C Hanish’s form 4 insider trades.
Insider Ownership Summary of Arnold C Hanish
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2022-06-03 | director |
| OMER | Omeros Corp | 2023-05-22 | director |
| LLY | Eli Lilly and Co | 2012-05-18 | Chief Accounting Officer |
Arnold C Hanish Latest Holdings Summary
Arnold C Hanish currently owns a total of 3 stocks. Among these stocks, Arnold C Hanish owns 26,155 shares of Eli Lilly and Co (LLY) as of May 18, 2012, with a value of $21 Million and a weighting of 99.75%. Arnold C Hanish owns 12,400 shares of Omeros Corp (OMER) as of May 22, 2023, with a value of $52,948 and a weighting of 0.25%. Arnold C Hanish also owns 232 shares of Salarius Pharmaceuticals Inc (SLRX) as of June 3, 2022, with a value of $346 and a weighting of 0%.
Latest Holdings of Arnold C Hanish
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co | 2012-05-18 | 26,155 | 818.86 | 21,417,283 |
| OMER | Omeros Corp | 2023-05-22 | 12,400 | 4.27 | 52,948 |
| SLRX | Salarius Pharmaceuticals Inc | 2022-06-03 | 232 | 1.49 | 346 |
Holding Weightings of Arnold C Hanish
Arnold C Hanish Form 4 Trading Tracker
According to the SEC Form 4 filings, Arnold C Hanish has made a total of 0 transactions in Eli Lilly and Co (LLY) over the past 5 years. The most-recent trade in Eli Lilly and Co is the sale of 1,295 shares on May 18, 2012, which brought Arnold C Hanish around $52,435.
According to the SEC Form 4 filings, Arnold C Hanish has made a total of 1 transactions in Omeros Corp (OMER) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Omeros Corp is the sale of 5,000 shares on May 22, 2023, which brought Arnold C Hanish around $32,300.
According to the SEC Form 4 filings, Arnold C Hanish has made a total of 9 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 140 shares on June 3, 2022, which cost Arnold C Hanish around $5,040.
Insider Trading History of Arnold C Hanish
- 1
Arnold C Hanish Trading Performance
GuruFocus tracks the stock performance after each of Arnold C Hanish's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arnold C Hanish is -29.06%. GuruFocus also compares Arnold C Hanish's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arnold C Hanish within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arnold C Hanish's insider trading performs compared to the benchmark.
Performance of Arnold C Hanish
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.67 | | | | | |
| Relative Return to S&P 500(%) | 4.44 | | | | | |
Arnold C Hanish Ownership Network
Ownership Network List of Arnold C Hanish
Ownership Network Relation of Arnold C Hanish
Arnold C Hanish Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
Arnold C Hanish is the director of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , director & Chief Executive Officer David J. Arthur , and Chief Financial Officer Scott Jordan .
Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
Arnold C Hanish Mailing Address
Above is the net worth, insider trading, and ownership report for Arnold C Hanish. You might contact Arnold C Hanish via mailing address: 201 Elliott Avenue West, Seattle Wa 98119.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
